Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | SLC1A5 | Q15758 | 1/20 | 0.47 |
| ▸ | GRM8 | O00222 | 1/20 | 0.46 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.43 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.43 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23099298 | 1.00 | L3MBTL1 (0.49) | L3MBTL1SLC1A5GRM8GRM4KDM4E | |
| SCHEMBL31374444 | 0.85 | TDP1 (0.59) | L3MBTL1SLC1A5KDM4ETSHRRAB9A | |
| SCHEMBL24354984 | 0.80 | SLC1A5 (0.73) | SLC1A5KDM4ERAB9ASLC7A5LMNA | |
| SCHEMBL15953935 | 0.79 | L3MBTL1 (0.59) | L3MBTL1KDM4ETSHRRAB9AKMT2A | |
| SCHEMBL552291 | 0.79 | CYP19A1 (0.62) | L3MBTL1KDM4ETSHRRAB9AKMT2A | |
| SCHEMBL23099268 | 0.77 | GABRP (0.49) | L3MBTL1SLC1A5GRM8GRM4RAB9A | |
| SCHEMBL23099269 | 0.77 | GABRP (0.49) | L3MBTL1SLC1A5GRM8GRM4RAB9A | |
| SCHEMBL19688301 | 0.76 | TDP1 (0.59) | L3MBTL1KDM4ETSHRRAB9AKMT2A | |
| SCHEMBL31657163 | 0.75 | TDP1 (0.69) | SLC1A5RAB9AKMT2ASLC7A5LMNA | |
| Hydrochloric Acid SCHEMBL27539891 | 0.75 | L3MBTL1 (0.51) | L3MBTL1KDM4ETSHRRAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11840496-B2 | Method of preparing L-homoserine | CJ CHEILJEDANG CORPORATION (KR) | 2023-12-12 | — | — | US | disclosed |
| US-11840496-B2 | Method of preparing L-homoserine | CJ CHEILJEDANG CORPORATION (KR) | 2023-12-12 | — | — | US | disclosed |
| WO-2021049876-A1 | METHOD FOR PRODUCING L-HOMOSERINE | 씨제이제일제당(주) | 2021-03-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11840496-B2 | Method of preparing L-homoserine | LSS, PSPH, CTH | L3MBTL1 1799/4885SLC1A5 782/4885GRM8 857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.